<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2020-3648</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-3648</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Результаты трехлетнего наблюдения и оценка качества жизни после тромбэндартерэктомии из легочной артерии</article-title><trans-title-group xml:lang="en"><trans-title>Results of a three-year follow-up and quality of life dynamics after pulmonary thromboendarterectomy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2845-930X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клинкова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Klinkova</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м.н., н. с. группы клинической физиологии Центра анестезиологии и реаниматологии</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">Klinkovaas@ngs.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8488-0858</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каменская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kamenskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., в. н.с. группы клинической физиологии Центра анестезиологии и реаниматологии</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">o_kamenskaya@meshalkin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3219-0107</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логинова</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Loginova</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., с.н.с. группы клинической физиологии Центра анестезиологии и реаниматологии</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">i_loginova@meshalkin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9818-8678</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернявский</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyavsky</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., профессор, директор</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">a_cherniavsky@meshalkin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6661-7826</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Едемский</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Edemsky</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>в тый хирург кардиохирургического отделения аорты и коронарных артерий</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">a_edemskiy@meshalkin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7622-8384</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хабаров</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khabarov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., в. н.с. лаборатории оперативной хирургии и лимфодетоксикации, зав. отделением анестезиологии и реанимации</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">hdv@ngs.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8591-6461</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ломиворотов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lomivorotov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., член-корр. РАН, руководитель Центра анестезиологии и реаниматологии</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">vv_lomivorotov@meshalkin.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ Национальный медицинский исследовательский центр им. акад. Е. Н. Мешалкина Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Meshalkin National Medical Research Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт клинической и экспериментальной лимфологии — филиал ФГБНУ Федеральный Исследовательский Центр Институт Цитологии и Генетики Сибирского Отделения Российской Академии Наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Clinical and Experimental Lymphology, Federal Research Center Institute of Cytology and Genetics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>13</day><month>01</month><year>2020</year></pub-date><volume>25</volume><issue>8</issue><fpage>3648</fpage><lpage>3648</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Клинкова А.С., Каменская О.В., Логинова И.Ю., Чернявский А.М., Едемский А.Г., Хабаров Д.В., Ломиворотов В.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Клинкова А.С., Каменская О.В., Логинова И.Ю., Чернявский А.М., Едемский А.Г., Хабаров Д.В., Ломиворотов В.В.</copyright-holder><copyright-holder xml:lang="en">Klinkova A.S., Kamenskaya O.V., Loginova I.Y., Chernyavsky A.M., Edemsky A.G., Khabarov D.V., Lomivorotov V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/3648">https://russjcardiol.elpub.ru/jour/article/view/3648</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценить результаты трехлетнего наблюдения больных хронической тромбоэмболической легочной гипертензией (ХТЭЛГ) и динамику качества жизни (КЖ) после тромбэндартерэктомии (ТЭЭ) из легочной артерии (ЛА).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены 125 больных ХТЭЛГ 49,7±11,9 лет. Трехлетнее наблюдение включало фиксирование неблагоприятных сердечно-сосудистых событий, перенесенные операции, летальный исход с момента выписки из стационара и включительно до трех лет. С помощью опросника SF-36 исследовались суммарные показатели физического и душевного благополучия до и через 3 года после ТЭЭ из ЛА. Методом многофакторного линейного регрессионного анализа проведена оценка факторов, влияющих на КЖ в отдаленном послеоперационном периоде.</p></sec><sec><title>Результаты</title><p>Результаты. За три года наблюдения в исследуемой группе больных неблагоприятные сердечно-сосудистые события составили 1,9%. Одному пациенту было проведено коронарное шунтирование и одному выполнена холецистэктомия. Повторных ТЭЭ из ЛА не проводилось. Суммарная трехлетняя выживаемость составила 90,4%.Исходно у больных ХТЭЛГ отмечался низкий уровень физического и психологического компонентов здоровья (&lt;40 баллов). Через 3 года после операции данные показатели статистически значимо увеличились (p&lt;0,05), но не превышали 50 баллов. Многофакторный линейный регрессионный анализ выявил неблагоприятное влияние наличия у больных резидуальной легочной гипертензии в раннем послеоперационном периоде на физический компонент здоровья через 3 года после ТЭЭ из ЛА. Другие факторы: возраст, пол, масса тела, сопутствующая патология, осложнения в госпитальном периоде, не оказали влияния на физический и эмоциональный аспекты КЖ.</p></sec><sec><title>Заключение</title><p>Заключение. Суммарная трехлетняя выживаемость у больных ХТЭЛГ после ТЭЭ из ЛА составила 90,4%. За период наблюдения не было зафиксировано повторных тромбоэмболических событий. Неблагоприятные сердечно-сосудистые события составили 1,9%. Через 3 года после операции физический и психический компоненты здоровья увеличились в сравнении с дооперационными показателями, но не превышали 50 баллов по опроснику SF-36. На физический аспект КЖ после операции влияет резидуальная легочная гипертензия, зафиксированная в раннем послеоперационном периоде.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To evaluate the results of a three-year follow-up of patients with chronic thromboembolic pulmonary hypertension (CTEPH) and quality of life (QOL) dynamics after pulmonary thromboendarterectomy (PTE).</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 125 patients with CTEPH aged 49,7± 11,9 years. Three-year follow-up included the recording of adverse cardiovascular events, surgeries, death during the period from the end of hospitalization and up to three years. The SF-36 questionnaire was used to assess physical and mental wellbeing before and three years after PTE. Multivariate linear regression was used to assess the factors affecting QOL in the long-term postoperative period.</p></sec><sec><title>Results</title><p>Results. During a three-year follow-up, adverse cardiovascular events was recorded in 1,9% of patients. One patient underwent coronary artery bypass graft surgery and one patient — cholecystectomy. Reoperative PTE was not carried out. The overall three-year survival rate was 90,4%.At baseline, patients with CTEPH had a low level of physical and mental well-being (&lt;40 points). Three years after the operation, these parameters significantly increased (p&lt;0,05), but did not exceed 50 points. Multivariate linear regression revealed an unfavorable effect of early postoperative residual pulmonary hypertension on the physical health three years after PTE. Other factors (age, sex, body weight, comorbidity, hospital acquired complications) did not affect the physical and emotional aspects of QOL.</p></sec><sec><title>Conclusion</title><p>Conclusion. Three-year survival rate in patients with CTEPH after PTE was 90,4%. During the follow-up period, no recurrent thromboembolic events were recorded. Adverse cardiovascular events were recorded in 1,9% of patients. Three years after surgery, the physical and mental health increased in comparison with preoperative values, but did not exceed 50 points on the SF-36 questionnaire. The physical aspect of QOL after surgery is affected by early postoperative residual pulmonary hypertension.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая тромбоэмболическая легочная гипертензия</kwd><kwd>тромбэндартерэктомия из легочной артерии</kwd><kwd>качество жизни</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic thromboembolic pulmonary hypertension</kwd><kwd>pulmonary thromboendarterectomy</kwd><kwd>quality of life</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(1):1801915. doi:10.1183/13993003.01915-2018.</mixed-citation><mixed-citation xml:lang="en">Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(1):1801915. doi:10.1183/13993003.01915-2018.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Konstantinides SV, Meyer G. The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism. Eur Heart J. 2019;40(42):3453-5. doi:10.1093/eurheartj/ehz726.</mixed-citation><mixed-citation xml:lang="en">Konstantinides SV, Meyer G. The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism. Eur Heart J. 2019;40(42):3453-5. doi:10.1093/eurheartj/ehz726.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Чернявский А. М., Едемский А. Г., Новикова Н. В. и др. под общ. ред. А. М. Чернявского. Хирургическое лечение хронической тромбоэмболической легочной гипертензии. ФГБУ “НМИЦ им. ак. Е. Н. Мешалкина” Минздрава России. Новосибирск: Издательство СО РАН, 2019. 318 с. ISBN: 978-5-7692-1665-7.</mixed-citation><mixed-citation xml:lang="en">Chernyavskiy АM, Edemskiy AG, Novikova NV, et al. Edited by Chernyavskiy АM. Surgical treatment of chronic thromboembolic pulmonary hypertension. E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation. Novosibirsk: Publishing House SB RAS, 2019. p 318. (In Russ.) ISBN: 978-5-7692-1665-7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mathai SC, Ghofrani H-A, Mayer E, et al. Quality of life in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2016;48(2):526-37. doi:10.1183/13993003.01626-2015.</mixed-citation><mixed-citation xml:lang="en">Mathai SC, Ghofrani H-A, Mayer E, et al. Quality of life in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2016;48(2):526-37. doi:10.1183/13993003.01626-2015.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Calderaro D, Prada LF, Souza R. Diagnosis and clinical investigation of patients presenting with pulmonary hypertension. Humbert M, editor. ESC CardioMed. 2018;2507-11. doi:10.1093/med/9780198784906.003.0584.</mixed-citation><mixed-citation xml:lang="en">Calderaro D, Prada LF, Souza R. Diagnosis and clinical investigation of patients presenting with pulmonary hypertension. Humbert M, editor. ESC CardioMed. 2018;2507-11. doi:10.1093/med/9780198784906.003.0584.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev. 2015;24(138):621-9. doi:10.1183/16000617.0063-2015.</mixed-citation><mixed-citation xml:lang="en">Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev. 2015;24(138):621-9. doi:10.1183/16000617.0063-2015.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Delcroix M, Lang I, Pepke-Zaba J, et al. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension. Circulation. 2016;133(9):859-71. doi:10.1161/circulationaha.115.016522.</mixed-citation><mixed-citation xml:lang="en">Delcroix M, Lang I, Pepke-Zaba J, et al. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension. Circulation. 2016;133(9):859-71. doi:10.1161/circulationaha.115.016522.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Инструкция по обработке данных, полученных с помощью опросника SF-36. http://therapy.irkutsk.ru/doc/sf36a.pdf (date of the application: 19.08.2014).</mixed-citation><mixed-citation xml:lang="en">Data processing instructions obtained by the SF-36 questionnaire. Electronic resource. Company Evidence. (In Russ.) http://therapy.irkutsk.ru/doc/sf36a.pdf (date of the application: 19.08.2014).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kamenskaya OV, Cherniavsky AM, Klinkova AS, et al. Efficiency of Various Cerebral Protection Techniques Used during the Surgical Treatment of Chronic Pulmonary Thromboembolism. J Extra Corpor Technol. 2015;47(2):95-102.</mixed-citation><mixed-citation xml:lang="en">Kamenskaya OV, Cherniavsky AM, Klinkova AS, et al. Efficiency of Various Cerebral Protection Techniques Used during the Surgical Treatment of Chronic Pulmonary Thromboembolism. J Extra Corpor Technol. 2015;47(2):95-102.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jenkins D, Madani M, Fadel E, et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160111. doi:10.1183/16000617.0111-2016.</mixed-citation><mixed-citation xml:lang="en">Jenkins D, Madani M, Fadel E, et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160111. doi:10.1183/16000617.0111-2016.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B. Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Chron Respir Dis. 2018;16:147997231878790. doi:10.1177/1479972318787906.</mixed-citation><mixed-citation xml:lang="en">Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B. Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Chron Respir Dis. 2018;16:147997231878790. doi:10.1177/1479972318787906.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kamenskaya O, Klinkova A, Loginova I, et al. Determinants of Health-Related Quality of Life 1 Year after Pulmonary Thromboendarterectomy. Ann Vasc Surg. 2018;51:254-61. doi:10.1016/j.avsg.2018.02.019.</mixed-citation><mixed-citation xml:lang="en">Kamenskaya O, Klinkova A, Loginova I, et al. Determinants of Health-Related Quality of Life 1 Year after Pulmonary Thromboendarterectomy. Ann Vasc Surg. 2018;51:254-61. doi:10.1016/j.avsg.2018.02.019.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Madani M, Mayer E, Fadel E, et al. Pulmonary Endarterectomy. Patient Selection, Technical Challenges, and Outcomes. Ann Am Thorac Soc. 2016;3:S240-S247. doi:10.1513/annalsats.201601-014as.</mixed-citation><mixed-citation xml:lang="en">Madani M, Mayer E, Fadel E, et al. Pulmonary Endarterectomy. Patient Selection, Technical Challenges, and Outcomes. Ann Am Thorac Soc. 2016;3:S240-S247. doi:10.1513/annalsats.201601-014as.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jujo T, Tanabe N, Sakao S, et al. Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension. Kuwana M, editor. PLOS ONE. 2016;11(8):e0161827. doi:10.1371/journal.pone.0161827.</mixed-citation><mixed-citation xml:lang="en">Jujo T, Tanabe N, Sakao S, et al. Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension. Kuwana M, editor. PLOS ONE. 2016;11(8):e0161827. doi:10.1371/journal.pone.0161827.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015;24(136):263-71. doi:10.1183/16000617.00000815.</mixed-citation><mixed-citation xml:lang="en">Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015;24(136):263-71. doi:10.1183/16000617.00000815.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
